Glaucoma linked with higher mortality

Article

Glaucoma may be associated with an increased rate of mortality in adults.

Glaucoma may be associated with an increased rate of mortality in adults, according to a report published online ahead of print by Eye.

Liang Xu and co-workers from the Beijing Eye study examined 4,356 subjects for glaucoma in 2001, with a detected glaucoma frequency of 3.1%. All participants were invited for a follow-up examination in 2006.

Of the 4,356 subjects, 3,208 (73.6%) returned for a follow-up examination, while 124 (2.8%) were dead and 1,024 (23.5%) did not agree to be re-examined or had moved away. Mortality rate was significantly higher in the 135 glaucoma subjects (11.1%) than in the 4,221 patients without glaucoma (2.6%).

The study data therefore suggests that there may be an increased rate of mortality among glaucoma sufferers.

Recent Videos
Patrick C. Staropoli, MD, discusses clinical characterisation of Hexokinase 1 (HK1) mutations causing autosomal dominant pericentral retinitis pigmentosa
Richard B. Rosen, MD, discusses his ASRS presentation on illuminating subclinical sickle cell activities using dynamic OCT angiography
ASRS 2024: Socioeconomic barriers and visual outcomes in patients with rhegmatogenous retinal detachments, from Sally S. Ong, MD
Ashkan Abbey, MD, speaks about his presentation on the the CALM registry study, the 36-month outcomes of real world patients receiving fluocinolone acetonide 0.18 mg at the annual ASRS meeting in Stockholm, Sweden.
Nikoloz Labauri, MD, FVRS, speaks at the 2024 ASRS meeting about suspensory macular buckling as a novel technique for addressing myopic traction maculopathy
Jordana Fein, MD, MS, speaks with Modern Retina about the IOP outcomes with aflibercept 8 mg and 2 mg in patients with DME through week 48 of the phase 2/3 PHOTON trial at the annual ASRS meeting in Stockholm, Sweden.
John T. Thompson, MD, discusses his presentation at ASRS, Long-Term Results of Macular Hole Surgery With Long-Acting Gas Tamponade and Internal Limiting Membrane Peeling
ASRS 2024: Michael Singer, MD, shares 100-week results from the RESTORE trial
© 2024 MJH Life Sciences

All rights reserved.